Big - Pharma

A significant portion of these companies is owned by large institutional investors like Blackrock, Vanguard, and State Street, which collectively hold roughly 20% of the industry.

Significant efforts are underway to align U.S. drug prices with lower international rates. Big Pharma

Eli Lilly, Johnson & Johnson, AbbVie, and Roche are among the largest global players. A significant portion of these companies is owned